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Running title: The yeast Rho1 GEFs 
Summary 
Rho GTPases are regulated in complex spatiotemporal patterns that may be dependent, in 
part at least, on the multiplicity of their GTP exchange factors (GEFs). Here, we examine 
the extent of and basis for functional specialization of the Rom2 and Tus1 GEFs that 
activate the yeast Rho1 GTPase, the ortholog of mammalian RhoA. First, we find that 
these GEFs selectively activate different Rho1-effector branches. Second, the synthetic 
genetic networks around ROM2 and TUS1 confirm very different global in vivo roles for 
these GEFs. Third, the GEFs are not functionally interchangeable: Tus1 cannot replace 
the essential role of Rom2, even when overexpressed. Fourth, we find that Rom2 and 
Tus1 localize differently: Rom2 to the growing bud surface and to the bud neck at 
cytokinesis; Tus1 only to the bud neck but in a distinct pattern. Finally, we find that these 
GEFs are dependent on different protein co-factors:  Rom2 function and localization is 
largely dependent on Ack1, a SEL1 domain containing protein; Tus1 function and 
localization is largely dependent on the Tus1-interacting protein Ypl066w (which we 
name Rgl1). We have revealed a surprising level of diversity among the Rho1 GEFs that 
contributes another level of complexity to the spatiotemporal control of Rho1.  
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Introduction 
The RhoA family of GTPases control cell morphogenesis and cytoskeletal structure and 
dynamics. For example, RhoA is key to the establishment and function of the cytokinetic 
actin ring (CAR) that is required for proper cytokinesis at the end of mitosis in yeast and 
in mammalian cells (Takaki et al., 2008). RhoA is also a protooncogene, reinforcing the 
importance of proper cell structure to locomotion and metastasis (Sahai and Marshall, 
2002; Struckhoff et al., 2011). 
Rho GTPases, including RhoA, appear to function in very complex spatiotemporal 
patterns to drive proper cell morphogenesis (Pertz et al., 2006; Pertz, 2010). For example, 
recent work in mammalian cells points to RhoA being localized to discrete zones at the 
leading edge of a motile cell, as well as to distinct foci at the trailing edge of the cell 
(Pertz et al., 2006). This distribution at the cell cortex is highly dynamic and points to 
tight regulation of the position and activity of the GTPase as a function of time and 
movement. How such complex spatiotemporal patterns of RhoA activity are established 
is not well understood, but is likely to be dependent on spatiotemporal control of key 
regulators including the GTP exchange factors (GEFs) and GTPase activating proteins 
(GAPs) that directly affect its GTP status.  
The role of GEFs in the fine control of Rho GTPases is suggested by a number of 
observations. The number of potential Rho GEFs in any eukaryote is significantly more 
than the number of characterized Rho GTPases, e.g., some 69 putative Rho GEFs are 
found in the human genome sequence compared with 22 Rho GTPases (Rossman et al., 
2005; Garcia-Mata and Burridge, 2007).  Thus, there is sufficient plurality in the GEF 
population to localize and activate Rho GTPases in very complex patterns. Indeed, some 
GEFs can alter the specificity of their target Rho GTPase. For example, the Tiam1 GEF 
can directly bind to the Rac effectors IRSp53 and Wave2 thereby selectively activating 
only these Rac effectors (Connolly et al., 2005).  
The complexities of Rho GTPase signalling also apply in other eukaryotes, including the 
budding yeast Saccharomyces cerevisiae. The yeast RhoA ortholog, Rho1, appears to be 
regulated in a complex spatiotemporal pattern, acting at the growing bud surface during 
bud growth (Levin, 2005), at the bud neck during cytokinesis (Piekney et al., 2005; 
Wolfe and Glotzer, 2009) and at the vacuolar membrane where it mediates vesicle fusion 
and activation of the ABC transporter Ycf1 (Logan et al., 2010; Paumi et al., 2007).  
Rho1 is a key, essential hub protein in the Cell Wall Integrity (CWI) pathway in which 
activated Rho1-GTP binds directly to and activates multiple different downstream 
effectors including Protein Kinase C (Pkc1) which is required for cell integrity, the β-1,3-
glucan synthases Fks1 and Gsc2 critical for cell wall synthesis and the Bni1 formin, a key 
modulator of actin assembly ((reviewed in Levin, 2005).  
Rho1 can be activated by a number of different signals and inputs. For example, the state 
of the cell surface is sensed by a number of cell surface sensors especially Wsc1/Hcs77 
and Mid2 (Levin, 2005). Rho1 is also activated by Cyclin Dependent protein Kinase 
(CDK) at the G1/S transition (Kono et al., 2008) and by Polo kinase at cytokinesis 
(Yoshida et al., 2006). Furthermore, Rho1 activity is dependent on TORC2 signalling 
(Ho et al., 2008), TORC1 signalling (Petkova et al., 2010) and phospholipid metabolism 
(Audhya and Emr, 2002).  
In yeast, three GEFs activate Rho1: Rom1, Rom2 and Tus1. Rom1 and Rom2 are highly 
homologous proteins with Tus1 being more distantly related (Levin, 2005). The Rom1 
and Rom2 proteins contain a GEF/Dbl and a putative PH domain in the middle of the 
protein, domains characteristic of Rho GEFs (Rossman et al., 2005). The Rom1 and 
Rom2 proteins also contain a putative DEP domain N-terminal to the Dbl domain and a 
Citron Homology (CNH) domain at the C-terminus. This CNH domain is of unknown 
function but may be a protein-protein interaction domain that binds to Rho1 itself (Taira 
et al., 2004). Tus1 also contains a Dbl, a robust PH domain and CNH domains in the 
same order as in the Roms, but lacks a DEP domain. 
The three Rho1 GEFs function together to activate Rho1 in vivo. An otherwise inviable 
mutant lacking all three GEFs can be kept alive either by expressing a mutant version of 
Rho1 that exchanges nucleotides rapidly or by the absence of one of the Rho1 GTPase-
activating proteins, Sac7 or Lrg1, that inactivate Rho1 (Yoshida et al., 2009). 
Rom1 and Rom2 appear to be largely redundant, but with Rom2 being the major 
isozyme. Loss of Rom2 causes cell lysis at high temperature whereas loss of Rom1 has 
little phenotypic consequence. However, loss of both proteins is lethal, causing cell lysis 
at all temperatures (Ozaki et al., 1996).  Rom2 may also be partly redundant with Tus1. 
Although loss of Tus1 alone results in only subtle phenotypes (Hillenmeyer et al., 2008; 
Lesage et al., 2005; Schmelzle et al., 2002), loss of both Tus1 and Rom2 results in a 
strong temperature sensitive growth defect (Schmelzle et al., 2002; Krause et al., 2008).  
The Rho1 GEFs can be regulated similarly, e.g., Tus1 is an established, and Rom2 a 
probable, target of polo kinase (Cdc5) at cytokinesis (Yoshida et al., 2006). However, the 
GEFs can also be regulated differently, e.g., Tus1 is the only one of the three to be a 
substrate for cyclin-dependent protein kinase at the G1/S transition (Kono et al., 2008).  
The GEFs themselves seem to localize in distinct patterns, but side-by-side comparison 
of the Rom proteins and Tus1 has not been made. Rom2 localizes to the growing bud 
surface and to the bud neck during cytokinesis (Manning et al., 1997; Kobayashi et al., 
2005).  Tus1 is found at the incipient bud site early in the cell cycle and at the bud neck at 
cytokinesis (Kono et al., 2008; Yoshida et al., 2006). The mechanisms of targeting the 
GEFs to their subcellular locations are not known save for the bud neck targeting of Tus1 
and possibly Rom2 being triggered by phosphorylation by polo kinase Cdc5 (Wolfe and 
Glotzer, 2009; Yoshida et al., 2006). 
The GEFs are critical for the proper localization of Rho1, but only at late anaphase. The 
targeting of Rho1 to the bud cortex during most of the cell cycle is dependent on actin 
polarization (Ayscough et al., 1999) but independent of the Rho1 GEFs (Yoshida et al., 
2009). Indeed later, following actomyosin ring contraction, Rho1 accumulates at the bud  
neck via a GEF-independent mechanism that specifically requires the Rho1 PBS domain 
(Yoshida et al., 2009).   
Here we mainly focus on the two major Rho1 GEFs, Rom2 and Tus1. We find that these 
GEFs selectively target different Rho1 effector pathways. We find that these GEFs play 
different in vivo roles, have distinct subcellular localization patterns and separate 
localization mechanisms dependent on different, novel proteins. Our observations point 
to a surprising level of functional specialization among the Rho1 GEFs. 
Results 
The Rho1 GEFs differentially affect different Rho1-effector pathways 
Rho1 activates multiple different downstream effectors. It is possible that the Rho1 GEFs 
preferentially activate different subsets of effector pathways. We set out to determine the 
relative activity of three different effector branches in wild-type cells versus mutant cells 
lacking one of the Rho1 GEFs. In all cases, we failed to find any measurable 
consequence for the loss of Rom1, consistent with this isozyme playing a very minor role 
(data not shown). Here we focus on rom2Δ and tus1Δ mutants.  
First, Rho1 activates the vacuolar transporter Ycf1, a member of the MDR family of 
transmembrane metabolite transporters. This transporter is required to accumulate a red 
metabolic end product in the vacuole of ade2Δ cells and the extent of accumulation of 
this red product is proportional to the in vivo transport activity of Ycf1 (Paumi et al., 
2007). The accumulation of red pigment was assessed in double mutant ade2Δ.rom2Δ 
and ade2Δ.tus1Δ cells in comparison to ade2Δ single mutant cells. The absence of Tus1 
severely compromised Ycf1 activity in vivo, whereas loss of Rom2 resulted in only a 
mild transport defect (Fig. 1A). Both GEFs clearly contribute to Rho1-Ycf1 activity, but 
Tus1 plays a more important role.  
Second, Rho1 binds to and activates the plasma membrane glucan synthase enzyme that 
is required for the synthesis of β1,3-glucan (Levin, 2005). The steady state level of β1,3-
glucan in the cell wall is dependent, at least in part, on Rho1 function. We assayed glucan 
levels in rom2Δ and tus1Δ mutant cells using the aniline blue glucan binding dye and 
assaying either total aniline blue staining of cell populations (Shedletzkey et al., 1997) or 
the fraction of buds that stain positively for the dye in small-budded cells (Sekiya-
Kawasaki et al., 2002). We found that aniline blue staining was significantly reduced by 
loss of Rom2 but not by loss of Tus1 and in both assays (Fig. 1B,C). In contrast to the 
situation with Ycf1, our data are consistent with Rom2 playing a more important role 
than Tus1 in modulating the Rho1-glucan synthase effector pathway.   
Third, Rho1 binds to and activates Pkc1, the yeast protein kinase C homolog. The activity 
of Rho1-dependent Pkc1 function can be monitored using an Rlm1-lacZ reporter 
construct whose expression reflects the in vivo activity of Rho1-Pkc1 signalling (Jung et 
al., 2002). We measured the activity of this Rlm1-LacZ reporter in wild-type haploid and 
congenic deletion mutant cells grown in liquid cultures at room temperature. We found 
that mutant cells lacking Rom2 displayed reduced Rlm1-LacZ reporter activity, 
consistent with Rom2 serving as the main GEF controlling Rho1-Pkc1 (Fig. 2A).  
Surprisingly, we found that mutant cells lacking the Tus1 GEF displayed elevated Rlm1-
Pkc1 reporter activity (Fig. 2A), suggesting that Tus1 inhibits Rho1-Pkc1 activity.  This 
high reporter activity faithfully co-segregated with the deletion mutation in genetic 
crosses with wild-type cells, indicating that it is not the consequence of secondary 
mutations (data not shown).  
This high apparent activity of Rho1-Pkc1 signalling is also not an artefact of the assay 
system. Recent expression profiling identified 12 genes whose expression is strongly 
induced in a tus1Δ mutant (Benschop et al., 2010). We cross-referenced the expression of 
these genes in published profiles from cells in which Rho1-Pkc1 signalling is activated 
(Roberts et al., 2000). Of the 11 genes that are highly expressed in a tus1Δ mutant and for 
which data are available, 9 are induced when Pkc1 or Rho1 or both are activated in 
otherwise wild-type cells. Expression profiling is thus consistent with high activity of 
Rho1-Pkc1 signalling in the tus1Δ mutant.  
If Tus1 is indeed an inhibitor of Rho1-Pkc1 activity, overexpression of the protein should 
lower activity of the pathway. To overexpress the Rho1 GEFs, ROM2 and TUS1 were 
placed under the control of the inducible GAL1,10 promoter on a plasmid. We induced 
expression of the GEF genes in otherwise wild-type cells and assayed the consequence on 
Rlm1-LacZ reporter activity. We found that ectopic overexpression of ROM2 resulted in 
elevated reporter activity, consistent with Rom2 activating Rho1 (Fig. 2B). In contrast, 
we found that ectopic overexpression of TUS1 repressed reporter activity, consistent with 
its apparently paradoxical role as an inhibitor of Rho1-Pkc1 function (Fig. 2B). 
Why is Pkc1 activity upregulated in tus1Δ cells?  It is possible that loss of Tus1 may 
cause a defect in some Rho1-effector activity that is sensed by Rom-Rho1 complexes via 
a feedback loop resulting in activation of Pkc1 signalling.  If this model is correct, then 
we expect the elevated activity of the Pkc1 branch in a tus1Δ mutant to be dependent on 
activation of one or both of the Roms. Triple mutant cells lacking all three GEFs are 
inviable. We therefore assayed Rlm1-LacZ reporter activity in the double mutant cells 
lacking Tus1 and either Rom2 or Rom1. The tus1Δ.rom1Δ and tus1Δ.rom2Δ double 
mutant cells were viable, although the latter were slow growing and temperature sensitive 
(Schmelzle et al., 2002; Krause et al., 2008). We found that Rlm1-LacZ reporter activity 
was significantly reduced in both of the double mutant cells compared to tus1Δ single 
mutant cells (Fig. 2C). The high reporter activity seen in tus1Δ mutants is not suppressed 
by osmotic stabilization, suggesting that the absence of Tus1 is not triggering a cell 
surface defect. These data are consistent with, but does not definitively prove that, Tus1 
indirectly affecting the Rho1-Pkc1 effector branch by feedback control via both Rom1 
and Rom2 (see Discussion). The Pkc1 effector pathway provides the most dramatic 
evidence for functional specialization of the Rho1-GEFs.   
 
ROM2 and TUS1 synthetic genetic interaction networks. 
The apparent functional differences between Rom2 and Tus1 may be reflected in their 
global in vivo roles? The set of synthetic lethal or synthetic sick (SSL) genetic 
interactions for a gene gives an unbiased view of the global in vivo function of a query 
gene product. Here, we determined the networks of null-null SSL genetic interactions 
using rom2Δ or tus1Δ as query mutations and screened against the haploid deletion 
collection of ~4,700 single mutants using Synthetic Genetic Array (SGA) analysis (Tong 
et al., 2001; Tong et al., 2004).  Putative SSL interactions, where double mutants were 
inviable or slow growing, were identified in triplicate screens and confirmed either by 
random spore analysis or tetrad dissection or both.   
We found and confirmed 46 SSL interactions for ROM2 (supplementary material 
Table S1) and 31 interactions for TUS1 (supplementary material Table S2). Genes 
whose gene products act in cell organization and biogenesis or in transport dominate both 
of the networks. However, only five interactions are shared between the two networks 
(representing a mere 11% and 16% of each network respectively) (Fig. 3A). The SSL 
genetic networks are thus consistent with related but largely distinct in vivo roles for 
Rom2 and Tus1. 
The distinctive roles for the two major RhoGEFs is reinforced by considering SSL 
interactions that occur between the GEF genes and genes encoding other known 
components of the Rho1 signalling pathway. ROM2 interacts with ROM1, MID2 and 
ACK1, genes encoding known upstream activators of Rho1-Pkc1 signalling; BCK1, SLT2 
and SWI6, genes encoding components of the Pkc1-MAP kinase pathway; and FKS1, the 
gene encoding a glucan synthase isozyme, another Rho1 effector (Fig. 3B).  In contrast, 
TUS1 interacts with SPA2, PEA2 and BNI1, genes encoding components of the 
polarisome complex (Fig. 3C) and where Bni1 is another direct effector of Rho1. Only 
one gene SWI6, encoding a target of Rho1-Pkc1 signalling but with other independent 
functions, is found in both SSL networks.  
 
Tus1 cannot replace the Roms 
Loss of Rom2 results in a number of mutant phenotypes including hyper-sensitivity to 
benomyl treatment (Manning et al, 1997; our unpublished work). In contrast, loss of 
TUS1 leads to distinct phenotypes including hypersensitivity to chlorpromazine (our 
unpublished work). Importantly, we found that overexpression of TUS1 suppressed the 
hypersensitivity of rom2Δ mutant cells to benomyl and that overexpression of ROM2 
suppressed the hypersensitivity of tus1Δ mutant cells to chlorpromazine (supplementary 
material Fig. S1A). It thus appears that, under these conditions, overexpression of Rom2 
can directly replace or compensate for the loss of TUS1 and vice versa.  
Can overexpression of TUS1 suppress the inviability of rom1Δ.rom2Δ mutant cells 
lacking both Rom proteins? Over-expression of TUS1 was achieved either using a high 
copy plasmid containing the TUS1 gene and its normal regulatory elements (pTUS1) 
(Schmelzle et al., 2002) or a high copy plasmid in which expression of TUS1 is under the 
control of the GAL1,10 promoter (pGAL-TUS1) (Krause et al., 2008). These plasmids are 
sufficiently potent to suppress the lethality of tor2 mutants (Schmelzle et al., 2002: our 
unpublished work) and should thus be potent enough to suppress the lethality of 
rom1Δ rom2Δ double mutants if capable of doing do. The viability of haploid 
rom1Δ.rom2Δ transformants was determined in two ways. First, haploid double mutant 
cells harbouring one of the TUS1-expressing plasmids were generated by tetrad 
dissection of transformed double mutant diploid cells that were heterozygous for the 
rom1Δ and rom2Δ mutations. Viability of transformed double mutant haploid progeny 
was assessed on the appropriate media. Second, rom1Δ.rom2Δ haploid cells rendered 
viable by a URA3-marked plasmid containing the wild-type ROM2 gene were 
transformed with one of the TUS1-expressing plasmids. The ability of the doubly 
transformed cells to lose the URA3-marked plasmid containing ROM2 was assessed by 
growth in the presence of 5 fluoroorotic acid (5FOA) and on the appropriate media.   
In each experiment, we found that overexpression of TUS1 either via pTUS1 or pGAL-
TUS1 could not suppress the inviability of cells lacking both ROM1 and ROM2 
(supplementary material Fig. S1B; data not shown). These data suggest that Rom1 and 
Rom2 share a unique, essential role that cannot be performed by Tus1, even when 
overexpressed.  
 
Rom2 and Tus1 localize differently 
Are the unique roles of the Tus1 and Rom2 GEFs in part regulated through differential 
localizations? TUS1 and ROM2 were epitope-tagged with GFP at their endogenous locus 
in otherwise congenic wild-type haploid cells of the BY4741 strain background.  These 
tagged alleles are functional, with the strains being phenotypically indistinguishable from 
untagged, wild-type strains (data not shown). 
We only observed Tus1-GFP localization during mitosis/cytokinesis.  Specifically, Tus1-
GFP localised to the bud neck at late anaphase B where it formed a continuous ring that 
underwent a robust contraction event after spindle breakdown (Fig. 4A and 
Supplementary material Fig. S2 and Movie S1). These observations indicate that Tus1 
is an integral component of the cytokinetic actomyosin ring (CAR).  Following CAR 
contraction, a second highly transient Tus1-GFP ring, with a weaker fluorescence signal 
intensity than the first, formed at the division site.  This single Tus1-GFP ring then splits 
to form two rings of weak intensity on either side of the bud neck (Fig. 4A and 
Supplementary material Fig. S2 and Movie S1).  The transient single ring likely 
represents Tus1-GFP associated with rings on either side of the thin primary septum, but 
too close to be resolved by microscopy. Subsequent formation and growth of the 
secondary septum allows these two rings to be resolved, leading to the observed split ring 
structures.  Tus1-GFP was also observed at the division site following cell separation, 
typically on the daughter cell side (Fig. 4A). 
We found that Rom2-GFP localises differently to Tus1-GFP.  Rom2-GFP appeared at 
very faint, often polarised cortical patch like structures throughout the cell cycle that were 
most obvious in timelapse movies (Supplementary Movie S2).  However, at several 
points in the cell cycle, Rom2-GFP concentrated at distinct structures giving rise to 
robust non-patch like signals. Rom2-GFP was first observed to concentrate at the 
incipient bud site as a bright focus (Fig. 5).  In small budded cells with a single spindle 
pole body, Rom2-GFP was highly polarised towards the bud cortex, but this cortical 
localization became more isotropic and patch like in medium to large budded cells with a 
short bipolar or anaphase spindle respectively.   
In late anaphase, Rom2-GFP was lost from the bud cortex and repolarised towards the 
daughter cell side of the bud neck (Fig. 4B).  Following spindle breakdown, in two 
dimensions (XY), Rom2-GFP appeared to localise as a continuous band at the division 
site (Fig. 5); however, reconstructions demonstrated that this band represents a 
discontinuous ring which in time-lapse movies did not appear to undergo a robust 
contraction event (Supplementary material Fig. S3 and Movie S2). Instead, we 
occasionally observed what looked like Rom2-GFP passively tracking plasma membrane 
ingression (Supplementary material Figs. S3B and S3C).  Thus, in contrast to Tus1-
GFP, these data suggest that Rom2-GFP is not an integral component of the CAR.   
Reminiscent of Tus1-GFP, Rom2-GFP then formed split rings of weak signal intensity on 
either side of the bud neck.  Finally, prior to cell separation Rom2-GFP was often (but 
not always) lost from the mother cell side before that of the daughter, the latter signal 
typically persisting after cell separation (Fig. 5).   
 
Ack1 functions with Rom2 
We speculated that the different localization patterns and functions of Tus1 and Rom2 are 
due to different affinities for other, as yet unidentified partner proteins. Systematic 
analysis of the yeast proteome has identified a number of robust and novel protein-
protein interaction modules (Benschop et al., 2010). Importantly, that analysis places 
Rom2 and Tus1 in distinct complexes: Rom2 with the Ack1 protein, and Tus1 with the 
novel Ypl066w protein.  
Ack1 is a SEL1-domain containing protein that we have encountered previously. First, 
we identified Ack1 as a novel protein of unknown function that is required, like Rom2, 
for normal basal activity of Rho1-Pkc1 (Krause et al., 2008). Indeed, overexpression of 
ACK1, like ROM2, stimulates Rho1-Pkc1 activity (Krause et al., 2008). Second, we 
found that rom2Δ.ack1Δ double mutants are inviable (see SSL networks above 
(supplementary material Table S1). This inviability, like that of rom1Δ.rom2Δ, could 
be alleviated by the loss of the Rho1 GAP, Lrg1, suggesting that Rho1 activity is also 
limiting in the rom2Δ.ack1Δ double mutant (data not shown).  Thus Ack1, like Rom2, is 
an upstream activator of the Rho1-Pkc1 effector pathway. However, Ack1 must also act 
independently of Rom2 to promote Rho1 activity, possibly via Rom1.  
Overexpression of Ack1 in otherwise wild-type cells stimulates Pkc1 signalling as 
reflected in elevated Rlm1-LacZ reporter activity (Krause et al., 2008). Interestingly, 
overexpression of Ack1 could not elevate Rlm1-LacZ activity in a rom2Δ mutant 
(supplementary material Fig. S4A) nor could it alleviate the growth defects of 
rom1Δ.rom2Δ or rom2Δ.tus1Δ double mutant cells (data not shown; Krause et al., 2008). 
Taken together, our data are consistent with Ack1 functioning with both Rom1 and 
Rom2, but predominantly with Rom2. However, the activity of the Rom proteins cannot 
be totally dependent on Ack1 since ack1Δ mutant cells are viable whereas rom1Δ.rom2Δ 
mutant cells are not.   
 
Ypl066w functions with Tus1 
Tus1 and Ypl066w proteins are found in the same complex (Benschop et al., 2010). 
Indeed, tus1Δ  and ypl066wΔ mutant cells share very similar microarray expression 
profiles, consistent with a shared role (Benschop et al., 2010). Supporting this view, we 
found that ypl066wΔ mutants, like tus1Δ mutants, displayed high, rather than low, Rlm1-
LacZ reporter activity, indicating elevated Rho1-Pkc1 pathway activity (supplementary 
material Fig. S4B). Moreover, double mutant cells lacking both YPL066w and TUS1 
were viable and did not display any synthetic phenotypes (supplementary material 
Table S2). Furthermore, although overexpression of TUS1 lowered Rlm1-LacZ activity 
in otherwise wild-type cells (see before), overexpression did not affect reporter activity in 
an ypl066wΔ mutant (supplementary material Fig. S4B). We conclude that Ypl066w 
functions with Tus1.  
 
Localization of Rom2 is dependent on Ack1  
We tested if the localization of Rom2 or Tus1 is altered in ack1Δ mutant cells. All 
localization of Rom2-GFP to the bud neck was completely lost in the absence of Ack1 
(Fig. 5B,C). Additionally, a reduced proportion of ack1Δ cells with a single spindle pole 
body (typically small budded cells) successfully localised Rom2-GFP to the bud cortex 
(Fig. 5E), and, when it occurred, the signal intensity was dramatically (4.3 fold) weaker 
compared to wild type cells (Fig. 5D). Bud surface localization was also less persistent in 
the mutant and was already lost in cells with a short bipolar spindle (medium sized bud) 
(Fig. 5E). The localization of Rom2-GFP is thus profoundly dependent on Ack1. 
In contrast, the localization of Tus1-GFP is unaffected by the absence of Ack1 
(supplementary material Fig. S5). Ack1 is thus selectively required to localize Rom2 
and not Tus1.  
It is possible that the ack1Δ mutation affects Rom2-GFP localization indirectly by 
reducing the overall amount of the protein in the cell. However, we can rule this 
possibility out since the absence of Ack1 did not cause a decrease in the steady state level 
of Rom2-13myc or Tus1-13myc as assayed by Western blotting of whole cell protein 
extracts (Fig. S7). In conclusion, Ack1 behaves as a cofactor that is absolutely required to 
localize Rom2 (but not Tus1) to the bud neck at cytokinesis. The protein is also required 
for efficient localization of Rom2 to the bud cortex earlier in the cell cycle.  
 
Localization of Tus1 is dependent on Ypl066w/Rgl1 
We tested if the localization of Tus1 or Rom2 is altered in a ypl066wΔ mutant (Fig. 4). 
Tus1-GFP failed to localize efficiently to the bud neck at late anaphase (1% of anaphase 
ypl066wΔ cells (n=109) displayed a fluorescent signal at the bud neck, compared to 9% 
(n=105) in wild type).  Following spindle breakdown in the ypl066wΔ mutant, Tus1-GFP 
localised to the bud neck as a ring that underwent contraction (Fig. 4B,C), but the 
fluorescent signal intensity was drastically reduced (5.7 fold) in comparison to wild-type 
cells (Fig. 4D). Moreover, the second phase of ring localization is completely lost in the 
absence of Ypl066w (i.e., no split rings or signals at cell separation were detected – see 
Fig. 4C). This failure to detect a second wave of localization may indicate failure of this 
second phase in the mutant or it may be a consequence of reduced signal intensity, 
bringing the signal below our limit of detection.  
Localization of Rom2-GFP was essentially normal in the ypl066wΔ mutant cells. There 
were subtle changes in the distribution of Rom2-GFP localisations at cytokinesis but 
these are likely to be secondary consequences of a subtle effect of the mutation on 
cytokinesis itself (supplementary material Fig. S6). Ypl066w thus appears to be 
selectively required for the proper localization of Tus1, but not Rom2.  
We investigated whether the severe reduction in intensity of Tus1-GFP localization in the 
ypl066wΔ mutant may be due to a profound reduction in the steady state amount of the 
the protein. Western blot analysis of 13MYC-tagged alleles indicated that the steady state 
level of Tus1 (and indeed that of Rom2) was not affected by loss of Ypl066w 
(supplementary material Fig. S7). We conclude that Ypl066w is a cofactor that is 
required for the efficient localization of Tus1 during all phases of cytokinesis. This is the 
first known role for this novel gene product and we therefore name the gene RGL1 (Rho1 
GEF Localizing).  
Discussion 
Here, we show that the two principal GEFs for the Rho1 GTPase, Rom2 and Tus1, 
function very differently: Tus1 cannot perform the essential function of Rom2 
(supplementary material Fig. S1A) and the genetic interaction networks around ROM2 
and TUS1 are largely distinct (supplementary material Tables S1 and S2). 
Furthermore, we discovered some of the basis for these functional differences.  
First, the Rho1 GEFs selectively activate different Rho1-effector branches (Figs. 1, 2). 
To our knowledge, this is the first reported evidence of effector specificity by yeast Rho 
GEFs. Surprisingly, we also found that Tus1 acts as an inhibitor of Rho1-Pkc1 signalling 
(Fig. 2A,B): an apparently paradoxical role for a Rho1 activator. A profound difference 
in effector specificity between Rom2 and Tus1 may resolve this paradox. If Tus1 and 
Rom2 activate distinct subsets of Rho1-effector complexes (as they appear to do), then 
loss of Tus1 might result in a cellular defect that triggers activation of Rho1-Pkc1 
signalling by a signal communicated via the Rom GEFs. Loss of Tus1 could thus activate 
Rho1-Pkc1 activity. Indeed, Rho1 signalling is known to be under feedback control 
(reviewed in Levin, 2005) and lack of at least one Rho1 effector branch, Rho1-Bni1, is 
known to trigger activation of Rho1-Pkc1 activity (Krause et al., 2008). An alternative 
possibility is that loss of Tus1 simply liberates more Rho1 GTPase to be activated by the 
Rom GEFs. Such a model does not involve feedback control but is less parsimonious 
because loss of Tus1 should then lead to the activation of all Rho1 effector branches, and 
not just Rho1-Pkc1.  
Our work provides the first evidence that the yeast Rho1 GEFs preferentially activate 
subsets of the available Rho1-effector complexes. The mechanism of this effector 
specificity remains to be clarified, but the yeast system might prove a good model for 
exploring this poorly understood and important aspect of GTPase function (Cherfils and 
Zeghouf, 2011).  
How might the GEFs target different Rho1-effector complexes? One possible mechanism 
for effector specificity is co-localization, where a GEF and its cognate Rho1 effectors 
localize independently to the same subcellular compartment. Indeed, the distinct 
localization patterns of Rom2 and Tus1 (Figs. 4, 5) make this a tempting possibility. 
However, this mechanism demands that the effectors localize independently of the GEFs, 
a condition that is not met in key cases. For example, the localizations of Pkc1 and Bni1 
are dependent on, rather than independent of, activated Rho1 whose localization is in turn 
dependent on the GEFs (Andrews and Stark, 2000; Tolliday et al., 2002). Another 
possible mechanism for effector specificity involves effector tethering, where the GEF 
binds to both the GTPase and the effector to form a stable ternary complex, as appears to 
be the case for the Rac GEF Tiam1 and the Rac effectors IRSp53 and Wave2 in 
mammalian cells (Connolly et al., 2005). No physical association between a Rho1 GEF 
and any Rho1 effector has been reported to date. However, the association between 
Rom2 and Ack1 and between Tus1 and Ypl066w (Benschop et al., 2010) suggests that 
the GEFs are indeed part of novel, higher order complexes. It is possible that the GEFs 
associate with their cognate effectors on biological membranes but where the complexes 
do not survive routine biochemical purification. The search for such GEF complexes 
deserves renewed vigour.   
Here, we also find that the sub-cellular localizations of Rom2 and Tus1 are different, 
complex and highly dynamic (Figs. 4, 5). We found that Rom2, but not Tus1, localizes to 
the growing bud surface and to polarised cortical patches through the cell cycle. These 
observations are consistent with the key role that the Rom2 plays in proper growth of the 
bud surface, a function that Tus1 cannot perform.   
Both Rom2 and Tus1 localize to the bud neck during cytokinesis, but in distinct patterns 
consistent with different primary roles: Rom2 in septum growth and Tus1 in CAR 
function. Rom2 localizes to the division site in late anaphase, but first to the daughter 
side of the bud neck and then, following spindle breakdown, to a discontinuous ring that 
does not undergo robust contraction (Fig. 5). We infer that Rom2-GFP does not associate 
with the CAR but tracks the base of the constricting plasma membrane either side of the 
forming primary septum. Rom2 then forms discontinuous rings on either side of the bud 
neck during formation of secondary septum. The ring on the mother cell side is 
preferentially (but not always) lost prior to cell separation, whilst the ring on the daughter 
cell side persists after cell separation. Together, these localisation patterns support a 
primary role for Rom2 in promoting septation, consistent with prior genetic analysis 
(Yoshida et al., 2006; Yoshida et al., 2009). In contrast to Rom2, Tus1 initially localizes 
to a single ring at the bud neck in late anaphase (Fig. 4). This ring contracts to a single 
focus following spindle breakdown consistent with Tus1 being an integral component of 
the CAR, as was suggested by previous work (Yoshida et al., 2006, 2009). After CAR 
contraction, there is a second, weaker localization of Tus1 to a highly transient ring 
structure at the bud neck that subsequently appears to split into two rings..  
It is already known that the Rho1 GEFs themselves are required for the specific 
localizations of Rho1 in all phases of the cell cycle up to CAR contraction (Yoshida et 
al., 2009). Our discovery of the complex and distinct localizations of Rom2 and Tus1 
suggest that each GEF contributes to a distinct subset of this dynamic localization, and 
thus localized activation, of Rho1. Later in cytokinesis, after CAR contraction, Rho1 can 
be localized independently of the GEFs to the bud neck (Yoshida et al., 2009). However, 
the activity of Rho1 is still dependent on the GEFs at this late stage in cytokinesis 
(Yoshida et al. 2009). The zone of active Rho1 in late cytokinesis is thus dictated by the 
localizations of Rho1 and the GEFs (and presumably the GAPs, which may also be 
functionally diverse: Schmidt et al., 2002) and their intersection.  
The dynamics of Rho1 GEF localization at cytokinesis is unexpectedly complex, a 
complexity that may be required to properly control and orchestrate the different phases 
of cytokinesis and cell separation. Indeed, our discovery of the effector selectivity of the 
GEFs allows for different Rho1-effector branches to be activated in complex 
spatiotemporal patterns during cytokinesis. For example, it is tempting to speculate that, 
during cytokinesis, Tus1 selectively localizes and activates Rho1-Bni1 to drive CAR 
formation, whereas Rom2 primarily localizes and activates Rho1-Pkc1 to drive 
membrane and cell wall synthesis during septation. Much work remains to be done to test 
this model.  
Here, we also report specific molecular roles for two novel regulators of Rho1 signalling, 
Ack1 and Rgl1(Ypl066w) (Figs. 4, 5). These proteins are specific cofactors for Rom2 
and Tus1 respectively and are important for both the function and localization of these 
Rho1 GEFs: Rom2 function and localization are dependent on Ack1 but not on Rgl1; 
whereas Tus1 function and localization are dependent on Rgl1 but not on Ack1. The 
localization mechanisms for the Rho1 GEFs are thus distinct, even when the localizations 
look superficially similar e.g., during secondary septum deposition late in cytokinesis.  
These Ack1 and Rgl1 cofactors seem to differentially affect different subpopulations of 
each GEF, raising the possibility that other cofactors remain to be discovered. For 
example, Ack1 affects both the bud neck and the bud surface localizations of Rom2, but 
to different extents: the bud neck localizations of Rom2 (but not Tus1) are fully 
dependent on Ack1 whereas the bud surface localizations of Rom2 are largely, but not 
completely dependent on Ack1 (Figs. 4, 5). The residual localization of Rom2 to the bud 
surface in the absence of Ack1 helps explain why the phenotype of ack1Δ mutant cells is 
less severe than for rom2Δ cells.  In the case of Rgl1, it seems partly required for the 
localization of Tus1 to the CAR but fully required for the subsequent septum localization 
of Tus1. Furthermore, Tus1 activated the Ycf1 lysosomal transporter.  This activation 
seems to be independent of Rgl1 (our unpublished work), suggesting that Rgl1 may be a 
bud neck selective subunit of Tus1 signalling complexes.  
The discovery of novel cofactors for the Rho1 GEFs adds a new layer of complexity to 
the regulation of the Rho1 GTPase. The study of these cofactors will shed light on the 
mechanisms that activate and target the Rho GEFs to different sub-cellular compartments 
and may even inform how these GEFs activate the appropriate subsets of available Rho 
effectors at each location. GEF cofactors may be a common aspect of GTPase switches, 
with some other examples are already known e.g., the CYK-4 cofactor for the Ect2 GEF 
of mammalian Rac GTPase (Yüce et al., 2005). 
Overall, our analysis of Rom2 and Tus1 function reveals a surprising level of complexity 
in the spatio-temporal control of Rho1 and its effectors. The specialization of the 
different GEFs that act on a given GTPase is likely to be a universal aspect of Rho 
biology.  
 
Materials & Methods 
 
Media, chemicals, and transformation 
The rich yeast medium (YPD) consisted of 1 % Bacto yeast extract (Difco), 2 % peptone 
(Difco), and 2 % glucose. Synthetic derived medium (SD, SGal/Suc) contained 0.67 % 
yeast nitrogen base without amino acids (Difco) and 2 % glucose, or 2 % galactose and 
0.005 % sucrose respectively with the appropriate nutrient supplements and drug 
additions where appropriate. Solid media were as described above, with the addition of 2 
% Bacto agar (Difco). Chemicals were from Sigma-Aldrich unless stated otherwise. 
Restriction enzymes were from New England Biolabs. All transformations were 
performed using the conventional lithium acetate method (Geitz et al., 1995). 
Plasmids and yeast strains used 
Plasmids and yeast strains used in this study are listed in supplementary material 
Tables S4 and S5 respectively. Double mutants were generated by mating two single 
mutant haploid strains of opposite mating type, selecting for the diploid, and then 
sporulating the diploid.  The spores were dissected and double mutants were identified by 
marker analysis. In the case of the generation of ack1rom2lrg1 and rom1rom2lrg1, LRG1 
was deleted from the parent strain using an lrg1::LEU2 construct as previously described 
(Stewart et al., 2007). 
Generation of pGAL-ROM2 
The plasmid expressing full length ROM2 under the control of the GAL1,10 promoter  
was generated by inserting ROM2 into the vector, pGREG535, by homologous 
recombination. This vector contains a GAL1,10 promoter and a hemagglutinin tag 
(Jansen et al., 2005). The vector was digested with SalI to remove its HIS+ marker. PCR 
amplified gene (using GregRom2F and GregRom2R) was cotransformed with SalI-
digested pGREG535 into wild type yeast cells. Transformants were selected on SD-Leu 
plates. Plasmid DNA from five independent yeast colonies was transformed into XL1-
Blue Escherichia coli cells (Stratagene). Plasmid DNA was purified, and the presence 
and orientation of an insert were confirmed by restriction digestion. The function of the 
plasmids was confirmed by in vivo complementation of the rom2 mutant phenotypes. 
Ycf1 Assay 
The accumulation of red pigment in ade2Δ strains was measured essentially as described 
by Chaudhuri et al., 1997. 15 ml cell cultures were incubated overnight at 21 °C. The 
OD600 of each culture was taken and the same amount of cells were placed at 4 ˚C for 2 
days to enhance the pigment development. All the cells were pelleted and resuspended in 
500 ml 5% sulphosalicylic acid (Sigma) and lysed by bead beating. Lysates were 
centrifuged at high speed for 5 min. The supernatant removed and saved. The beads were 
washed with a further 500 ml 5% sulphosalicylic acid, centrifuged and the supernatant 
again removed. The OD530 was measured for the combined supernatants. The experiment 
was repeated three independent times. 
Quantification of Glucan 
The amount of glucan was estimated by aniline blue binding as described in Shedletzky 
et al., 1997. Cells were grown to mid-logarithmic phase, washed twice and resuspended 
in TE buffer to an OD600 0.2 in a total volume of 500 ml. NaOH was added to a final 
concentration of 1N. The glucan was then solubilized by incubating the samples at 80ºC 
for 30 minutes. 2.1 ml aniline blue mix (0.03 % aniline blue, 0.18 N HCl, 0.49 M 
glycine/NaOH) was added and samples incubated at 50 ºC for 30 minutes and at room 
temperature for a further 30 minutes. Fluorescence was quantified using a 
spectrofluorimeter (400 nm excitation; 460 nm emission). All determinations were done 
four independent times. 
The activity of glucan synthase was also estimated by quantifying the fraction of buds 
that stain positive for aniline blue in small-budded cells in cultures grown to mid-log 
phase in YPD and using a confocal microscope, as described by Sekiya-Kawasaki et al. 
(2002). 
Determination of Pkc1 pathway activity 
We determined the relative amount of basal Slt2 activation in cells using a RLM1-LacZ 
reporter construct (Jung et al., 2002) as described in Stewart et al (2007). 
Synthetic Genetic Array Analysis 
ROM2 and TUS1 were individually deleted from the query strain and the SGA was 
performed as described by Tong et al., 2001. 
Random Spore Analysis 
The SGA positives were confirmed by random spore analysis using double heterozygous 
diploids taken during the SGA analysis according to Tong et al., 2001, but with 
additional selection for haploid spores as described by Rockmill et al., 1991. This extra 
selection step efficiently enriched for spores, bypassing the need to select against double 
heterozygous diploids. Spore suspensions were plated in SD medium lacking HIS (to 
select for MATa haploids) and containing 200 µg/ml G418 to select for candidate 
knockouts, 100 µg/ml nourseothricin to select for query gene knockout, or both, to select 
for double mutant haploids. The plates were incubated for two to three days at 30°C and 
then colony growth was scored. An SSL interaction was confirmed where little or no 
colony growth appeared but only on the plates containing both G418 and nourseothricin,  
Western blots 
Wild type, ack1, and ypl066w were transformed with pROM2-13MYC (from S. Yoshida).  
ack1 and ypl066w cells were mated to TUS1-13MYC cells (from D. Pellman). The diploid 
cells were selected and dissected. TUS1-13MYC, TUS1-13MYC ack1, and TUS1-13MYC 
ypl066w cells and the transformants were grown in appropriate medium overnight. A 
1:50 dilution was made with the overnight cultures and the freshly diluted cells were 
incubated for 3 hours at 21 ºC. One OD600 of cells were collected and resuspended in 100 
µl 120 mM NaOH. This was incubated on ice for 15 minutes and then 30 µl of 5X 
sample buffer was added.  The protein samples were boiled for 5 minutes. Any 
condensation was spun down and 30 µl was loaded on a 3-8 % Tris-Acetate gel 
(Invitrogen). The protein gel transfer and development of the immunoblot was as 
described in Krause & Gray, 2001. We used a mouse anti-MYC antibody from 
Calbiochem for the primary antibody and a sheep anti-mouse IgG-HRP antibody for the 
secondary from GE. 
Microscopy: Image acquisition   
Fluorescence images were acquired using a DeltaVision Core (Applied Precision) 
epifluorescence microscope fitted with an Olympus PlanApo 60x NA 1.4 objective, 
Chroma Technology Corporation filters, a CoolSNAP HQ CCD camera (Roper 
Scientific) and Applied Precision softWoRx suite imaging software (v4.0.0 release 16) 
run on CentOS (release 4.7) operating system.  The instrument controller ran version 5.40 
sub a build 0113 software.   
Live cell microscopy was performed by mounting cells in the appropriate pre-warmed 
media on 2.5% (w/v) agarose (Formedium) pads (made with the appropriate media).  Still 
images consisting of Z-stacks (21 Z-sections, 0.2 micron spacing between planes) were 
acquired using the appropriate filter set and 3 second exposures for Tus1-GFP, Rom2-
GFP and eCFP-Tub3 fusion proteins.  Time lapse Z-stacks (comprising 18 Z-sections, 0.2 
micron spacing between planes) were acquired every 1 minute for either 35 minutes 
(Tus1-GFP) or 45 minutes (Rom2-GFP) using 3 second exposures.  Acquired 
fluorescence images were deconvolved with softWoRx using 15 iterations and the 
conservative algorithm (all other deconvolution parameters were set at their default 
values).   
Microscopy: Analysis  
Image data was processed/assembled using ImageJ v1.44m, Adobe Photoshop CS5 and 
Adobe illustrator CS5.  Graphs were plotted using SigmaPlot v11.2.0.11 (SYSTAT). 
Kymographs and montages were made from acquired time-lapse image sequences by 
reconstructing pixel data at the bud neck using the ImageJ (v1.44m) reslice command.  
Specifically, to generate kymographs, a range of Z-sections that spanned the bud neck 
region across all time points in acquired four dimensional (XYZT) time-lapse image 
sequences were subjected to a maximal intensity projection producing a three 
dimensional (XYT) image sequence.  The reslice command (without interpolation) was 
then invoked from a straight line selection drawn adjacent and horizontal to the mother 
bud axis that was slightly longer than the bud neck width.  Reslice output spacing was set 
to a value equivalent to the voxel depth (i.e. 0.2 microns), slice count was set at 5 (care 
being taken that this was sufficient in each case to encompass the 2-dimensional (XY) 
fluorescent signal at the bud neck at each time-point).  The resulting stack of orthogonal 
slices was subjected to a maximal intensity projection and 90° CCW rotation to yield the 
resulting kymograph.  Montages were generated using the same procedure, except the 
reslice command was invoked from straight line selections drawn on the native four 
dimensional time-lapse image sequence (XYZT).   
Tus1-GFP and Rom2-GFP fluorescence intensity at the bud neck and bud tips 
respectively was measured using ImageJ v1.44m.  A 3 pixel wide straight line or multi-
segmented line was used to trace the fluorescent signal at the bud neck or bud tip 
respectively and the mean pixel intensity within its boundaries calculated.  From this, 
mean background fluorescence across the same line positioned in the mother cell 
cytoplasm was subtracted.  Measurements were performed on a single z-section within 
the stack that had the highest signal intensity.   
Statistics 
Statistical analyses were performed according to Cummings et al. (2007). 
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Figure Legends  
Fig. 1.  The Rho1-GEFs, Rom2 and Tus1, differentially affect Rho1-effector 
pathways. (A) Ycf1 activity was determined in wild-type, rom2 and tus1 mutants.  We 
generated the double mutants, rom2 ade2 and tus1 ade2, and compared the amount of red 
pigmentation relative to an ade2 single mutant, where Ycf1 activity is required to acquire 
the red pigment in ade2 mutants.  The differences observed between ade2 and rom2 ade2 
tus1 ade2 are significant (0.05>p>0.01 and p<0.001 respectively). Note: for wild type 
cells, n=4; for ade2 cells, n=15; for ade2rom2 cells, n=6; and for ade2tus1 cells, n=4.  
The error bars shown represent standard error and we used student t-test to determine 
statistical significance.  (B) Glucan levels were determined in wild-type, rom2 and tus1 
cells using the fluorochrome aniline blue which complexes with 1,3-β-glucan.  The 
amount of fluorescence was determined for each mutant relative to the amount for the 
congenic wild type strain.  There was no significant difference between the levels found 
in wild type cells and tus1 mutant cells (p > 0.1); the difference between wild type and 
rom2 cells was significant (0.05>p <>0.01). For all cell types, n=4. The error bars shown 
represent standard error and statistical significance was calculated using the student t-test. 
(C) Wild type, rom2 and tus1 cells were stained with aniline blue and the percentage of 
stained buds in small-budded cells was determined. The percentage of small buds stained 
in rom2 mutant cells were significantly less than that observed in wild type cells 
(0.01>p>0.001).  The difference between wild type and tus1 cells was not significant 
(p>0.1). For all cell types, n=3.  The error bars shown represent standard error and 
statistical significance was determined using the student t-test. 
 
Fig. 2.  Rom2 and Tus1 have opposite affects on the Rho1-Pkc1 signalling pathway. 
(A) rom2 and tus1 and congenic wild type strains were transformed with a Rlm1-LacZ 
reporter construct and logarithmically growing cultures were assayed for β-galactosidase 
activity.  The relative reporter activity of a mutant was determined relative to congenic 
wild type cells.  In rom2 mutant cells, the relative activity of the reporter construct was 
significantly low (p < 0.001); whereas the relative activity in tus1 cells was significantly 
high (p < 0.05). Note: for wild type cells, n=28; for rom2 cells, n=12; and for tus1 cells, 
n=13.  The error bars shown represent standard error and statistical significance was 
calculated using the student t-test. (B) Wild type strains were transformed with a Rlm1-
LacZ reporter and either a vector, pGAL-ROM2, or pGAL-TUS1 and relative reporter 
activity determined as described above.  Overexpression of ROM2 enhanced relative 
reporter activity (p<0.001); whereas overexpression of  TUS1 inhibited it (p<0.001). 
Note: for wild type cells expressing an empty vector, n=26; for wild type cells 
overexpressing ROM2, n=22; and for wild type cells overexpressing TUS1, n=7. The 
error bars shown represent standard error and statistical significance was calculated using 
the student t-test. (C) rom1tus1 and rom2tus1 double mutants were generated and 
transformed with a Rlm1-LacZ reporter construct and relative reporter activity for the 
double mutants was determined as above and compared to those of the single mutants. 
The observed reporter activity levels in the double mutants, rom1tus1 and rom2tus1, was 
significantly higher than in the single rom1 (0.001<p<0.01) or rom2 (p<0.001) mutant, 
but lower than in the single tus1 mutant (0.01<p<0.05 and p<0.001 respectively). Note: 
for wild type cells, n=28; for rom2 cells, n=12; for tus1 cells, n=13; for rom1 cells, n=9; 
for rom2tus1, n=4; and for rom1tus1 cells, n=6. The error bars shown represent standard 
error and statistical significance was calculated using the student t-test. 
 
Fig. 3.  The Synthetic Genetic Interaction Networks of ROM2 and TUS1 are largely 
distinct.  (A) ROM2 or TUS1 genes were deleted from the SGA query strain as described 
by Tong et al., 2000.  SGA analysis was performed separately on each null mutant.  The 
positives were confirmed by random spore analysis (and also by tetrad analysis in some 
cases) (see supplementary material online). A set diagram showing the extent of 
overlap between the two networks is shown. The Rho1-Pkc1 signalling pathway is 
displayed with (B) ROM2 and (C) TUS1 genetic interactors highlighted in bold and 
underlined respectively.  
Fig. 4. The Spatial and temporal pattern of Tus1-GFP localization in ypl066w cells. 
(A) Tus1-GFP localization is shown in an otherwise wild type background expressing N-
terminal eCFP-tagged Tub3 which marks the spindle pole body (SPB) and the mitotic 
spindle. The image series is a composite of cells representative of the distinct phases of 
localization. Scale bars = 2 µm. (B) Average intensity projection images of representative 
ypl066w cells co-expressing Tus1-GFP and eCFP-Tub3 (note: ‘split band’ and ‘signal at 
cell separation’ categories were not observed in ypl066w cells).  Scale bars = 2 µm.  (C) 
Histogram of wild type (n=209), ypl066w (n=170) and ack1 (n=144) cells co-expressing 
Tus1-GFP and eCFP-Tub3.  All cells included in the sampling were post-mitotic spindle 
breakdown with two visible spindle pole bodies.  (D) Wild type and ypl066w cells 
expressing Tus1-GFP were mixed in a 1:1 ratio and the fluorescence intensity of the GFP 
signal at the bud neck in cells following spindle breakdown was measured in the same 
field of vision (specifically, only cells with the ‘band (no septum)’ category signal were 
measured).  The ypl066w cells were marked by co-expression of eCFP-Tub3 (wild type 
cells harboured an ‘empty’ vector (eV) instead). 
 
Fig. 5.  The Spatial and temporal pattern of Rom2-GFP localization in ack1 cells. 
(A) Rom2-GFP localization in a wild type background expressing N-terminal eCFP 
tagged Tub3. The image series is a composite of cells representative of the distinct phases 
of localization.  All images are average intensity projections.  Scale bars = 2 µm. (B) 
Average intensity projection images of representative ack1∆ cells co-expressing Rom2-
GFP and eCFP-Tub3.   Scale bars = 2 µm.  (C) Histogram of post-anaphase wild type 
(n=181), ack1 (n=155) and ypl066w (n=223) cells co-expressing Rom2-GFP and eCFP-
Tub3 and scored for Rom2-GFP bud neck signals.  (D) Wild type and ack1 cells 
expressing Rom2-GFP were mixed in a 1:1 ratio and the fluorescence intensity of the 
GFP signal at bud tips in small budded cells with a single spindle pole body was 
measured in the same field of vision.  The ack1 cells were marked by eCFP-Tub3 
expression (wild type cells harboured an ‘empty’ vector (eV) instead).  (E) Histogram of 
wild type, ack1 and ypl066w cells co-expressing Rom2-GFP and eCFP-Tub3 and scored 
for Rom2-GFP bud tip signals at the cell cycle stages indicated.  
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Supplemental Material  
 
Supplementary Movie Legends: 
 
Movie S1.  Tus1-GFP time lapse.  Movie (4 frames/sec) constructed from the image 
series presented in Supplemental Figure 2A. 
Movie S2.  Rom2-GFP time lapse. Movie (4 frames/sec) constructed from the image 
series presented in Supplemental Figure 3A. 
 
Supplementary Table Legends 
 
Table S1.  Synthetic genetic array results for rom2. ROM2 was deleted from the query 
strain and the SGA (n=3) was performed as described by Tong et al., 2001.  The positives 
that were found in 2 or all 3 screens were then confirmed using random spore analysis. 
Table S2.  Synthetic genetic array results for tus1. TUS1 was deleted from the query 
strain and the SGA (n=3) was performed as described by Tong et al., 2001.  The positives 
that were found in 2 or all 3 were then confirmed using random spore analysis. 
Table S3. Summary of genetic interactions between ACK1, RGL1/YPL066W and the 
Rho1 GEF genes. 
Synthetic lethal interactions are marked with a minus sign (-, inviable double mutants), 
viable combinations with a plus sign (+, viable double mutants). 
Table S4.  List of plasmids used in this study. 
Table S5.  List of yeast strains used in this study.  All yeast strains are in the yeast 
deletion background (BY4741). 
 
 
Supplementary Figure Legends: 
 
Fig. S1.  Suppression of Rho1-Gef mutants.  (A) Wild type, rom2 and tus1 strains were 
transformed with a vector control, pROM2, or pTUS1.  The transformed strains were 
tested for their sensitivity by serial dilutions on SD-URA plates containing either 20 
µg/ml benomyl or 200 µg/ml chlorpromazine.  Overexpression of TUS1 in a rom2 mutant 
suppresses its sensitivity to benomyl.  Overexpression of ROM2 in a tus1 mutant 
suppresses the chlorpromazine sensitivity of tus1 mutants. “+” = growth. “-“ = no 
growth.   (B) rom1rom2 mutants containing a URA3-marked ROM2 plasmid (pROM2) to 
maintain viablity were transformed with a vector control, pGAL-ROM2, or pGAL-TUS1.  
The transformed cells were treated with 5-FOA to select for loss of the pROM2 plasmid.  
However, only the pGAL-ROM2 containing strain was able to lose the pROM2 plasmid, 
indicating that Tus1 cannot suppress the viablity defect of a rom1rom2 double mutant. 
Fig. S2.  Time-lapse localization of Tus1-GFP.  (A) Maximum intensity projection 
images in the X-Y plane are shown from a representative single cell expressing Tus1-
GFP in a wild type background are shown.  Images were collected over 35 minutes at 1 
minute intervals and the scale bar is 2 µm. The asterix marks the beginning of the second 
phase localization signal and arrows indicate the two separate ring structures that are 
subsequently observed. (B) Time lapse series of three representative individual cells 
(n=38) presented as kymographs (scale bar = 3.5 min) and (C) as a montage (looking 
through the bud neck at consecutive time points). Numbers to the left and right refer to 
the time of image capture within the 35 min series. 
Fig. S3.  Time-lapse localization of Rom2-GFP. (A) Maximum intensity projection 
images in the X-Y plane are shown from two representative single cells within the same 
field of vision expressing Rom2-GFP in a wild type background are shown.  Images were 
collected over 45 minutes at 1 minute intervals and the scale bar is 2 µm. (B) Time lapse 
series of three representative individual cells (n=41) presented as kymographs (scale bar 
= 4.5 min) and (C) as a montage (looking through the bud neck at consecutive time 
points). Numbers to the left and right refer to the time of image capture within the 45-
minute series. 
Fig. S4. Ack1 and Ypl066w act via Rom2 and Tus1 respectively. (A) Overexpression 
of ACK1 does not elevate the Pkc1 signalling defect in a rom2 mutant.  Congenic wild 
type and rom2 cells were transformed with the Rlm1-LacZ reporter construct and either a 
vector control or pGAL-ACK1.  β-galactosidase activity was assayed in the 
transformants.  The difference observed between the vector control and pGAL-ACK1 in 
rom2 mutant cells is not significant (n=3: p>0.1).  (B) Overexpression of TUS1 does not 
alter the observed high activity levels of Pkc1 signalling in a ypl066w mutant. Congenic 
wild type and ypl066w cells were transformed with the Rlm1-LacZ reporter construct and 
either a vector control or pGAL-TUS1.  β-galactosidase activity was assayed in the 
transformants.  The difference observed between the vector and pGAL-TUS1 in ypl066w 
mutant cells is not significant (n=3: p>0.1). All error bars shown represent Standard Error 
and statistical significance was determined by the student t-test.  
Fig. S5.  Localization of Tus1 is Ack1 independent.  Localization of Tus1-GFP is 
normal in an ack1 mutant. Average intensity projection images of representative 
anaphase and post-anaphase ack1 cells co-expressing Tus1-GFP and the eCFP-Tub3 
tubulin marker are shown. Scale bars = 2 µm.   
Fig. S6.  Rom2 localization is not dependent on Ypl066w. (A) Localization of Rom2-
GFP is mainly unaltered in a ypl066w mutant. Average intensity projection images of 
representative ypl066w cells co-expressing Rom2-GFP and the eCFP-Tub3 tubulin 
marker are shown. Scale bars = 2 µm. (B) Quantification of Rom2-GFP localization in 
post-anaphase ypl066w cells. 
Fig. S7.  The levels of the Rho1-GEFs are not altered in ack1 or ypl066w mutants. 
(A) The steady state level of Rom2 protein was determined in wild type, ack1, and 
ypl066w cells. Strains were transformed with a pROM2-13MYC plasmid.  The cells were 
selected and grown to log phase and subject to Western blotting for the MYC epitope.  A 
cross-reacting band also present in untransformed cells is shown as a loading control. (B) 
The steady state level of Tus1 protein was determined by Western blot analysis in wild-
type, ack1 and ypl066w cells. Strains were mated to TUS1-13MYC cells.  The diploid 
cells were selected and dissected.  Wild-type TUS1-13MYC, TUS1-13MYC ack1 and 
TUS1-13MYC ypl066w cells were grown to log phase before protein was extracted and 
subjected to Western blotting. A cross-reacting band is shown as a loading control.  
Table S1: SSL genetic interaction network around ROM2 
 
 
 
ORF Gene Name 
YBL058W SHP1 
YCL007C VMA9 
YDL185W TFP1 
YDL203C ACK1 
YDL232W OST4 
YDR017C KCS1 
YDR027C VPS54 
YDR174W HMO1 
YDR176W NGG1 
YDR207C UME6 
YDR245W MNN10 
YDR417c YDR417c 
YER167W BCK2 
YGL084C GUP1 
YGL200C EMP24 
YGR070W ROM1 
YGR252W GCN5 
YHL025W SNF6 
YHR030C SLT2 
YIL153W RRD1 
YIR023W DAL81 
YJL095W BCK1 
YJL124C LSM1 
YJL140W RPB4 
YJL175W YJL175W 
YJL183W MNN11 
YJR073C OPI3 
YJR118C ILM1 
YKL139W CTK1 
YLR332W MID2 
YLR342W FKS1 
YML016C PPZ1 
YMR003W AIM34 
YMR186W HSC82 
YMR274C RCE1 
YNL064C YDJ1 
YNR052C POP2 
YOL081W IRA2 
YOR035C SHE4 
YOR251C TUM1 
YOR332W VMA4 
YPL031C PHO85 
YPL101W ELP4 
YPL268W PLC1 
YPR023C EAF3 
Table S2: SSL genetic interaction network around TUS1 
 
ORF Gene Name 
YDL232W OST4 
YDR017C KCS1 
YDR432W NPL3 
YEL064C AVT2 
YEL067C YEL067C 
YER101C AST2 
YER119C-A AVT6 
YER149C PEA2 
YER153C PET122 
YFL014W HSP12 
YGL045W RIM8 
YHR111W UBA4 
YIL008W URM1 
YJL159W HSP150 
YLL021W SPA2 
YLR182W SWI6 
YLR330W CHS5 
YLR371W ROM2 
YLR384C IKI3 
YLR393W ATP10 
YMR003W AIM34 
YMR063W RIM9 
YMR116C ASC1 
YMR124W YMR124W 
YMR228W MTF1 
YMR274C RCE1 
YMR312W ELP6 
YNL271C BNI1 
YPL031C PHO85 
YPL086C ELP3 
YPL101W ELP4 
Table S3. Synthetic lethal genetic interactions 
 
 rom1 rom2 tus1 ack1 ypl066w 
rom1 NA - + + ND 
rom2 - NA + - + 
tus1 + + NA + + 
ack1 + - + NA + 
ypl066w ND + + + NA 
 
NA=not applicable 
ND=not determined 
 
 
Table S4: Plasmids used. 
 
Name of Plasmid Reference 
pGREG535 Euroscarf (Jansen et al., 2005) 
pRlm1-LacZ D. Levin (Jung et al., 2002) 
pGAL-TUS1 Krause et al., 2008 
pGAL-ACK1 Krause et al., 2008 
pGAL-ROM2 This study 
pROM2-13MYC S. Yoshida (Yoshida et al., 2006) 
pROM2 M. Hall (Schmidt et al., 1997) 
pTUS1 M. Hall (Schmelzle et al., 2002) 
pFA6a-GFP(S65T)::natMX6 Euroscarf (Van Driessche et al., 2005) 
YCplac33-pMET3::URA3 This study 
YCplac33-pMET3-eCFP-TUB3::URA3 This study 
 
 
 
Table S5:  Yeast strains used. 
Strain 
number 
Genotype Source 
JVG1367 MATa his3Δ1 leu2Δ met15Δ ura3Δ Euroscarf 
JVG1368 MATα his3Δ1 leu2Δ lys2Δ ura3Δ Euroscarf 
JVG1362 MATα Mfa1Δ::MFA1pr-HIS3 can1Δ his3Δ 
leu2Δ ura3Δ MET15+ lys2Δ 
C. Boone (Tong et al., 
2001) 
JVG4462 as JVG1368 ade2::kanMX Euroscarf 
JVG1371 as JVG1367 rom2::kanMX Euroscarf 
JVG3711 as JVG1362 rom2::natMX this study 
JVG1482 as JVG1367 tus1::kanMX Euroscarf 
JVG3713 as JVG1362  tus1::natMX this study 
JVG1552 as JVG1367 rom1::kanMX Euroscarf 
JVG4575 rom2::natMX rom1::kanMX +pROM2 this study 
JVG3654 rom2::natMX tus1::kanMX Krause et al., 2008 
JVG3659 rom2::natMX tus1::kanMX Krause et al., 2008 
JVG3990 rom1::kanMX tus1::natMX this study 
JVG4531 ade2::kanMX rom2::kanMX this study 
JVG4538 ade2::kanMX tus1::kanMX this study 
JVG3340 ack1::kanMX rom2::natMX lrg1::LEU2 this study 
JVG3339 rom2::natMX rom1::kanMX lrg1::LEU2 this study 
JVG4729 TUS1-13MYC::HIS D. Pellman(Yoshida et al., 
2006) 
JVG4762 ack1::natMX TUS1-13MYC::HIS this study 
JVG4799 rgl1::natMX TUS1-13MYC::HIS this study 
JVG1886 as JVG1367 ack1::kanMX Euroscarf 
JVG3713 as  JVG1362 ack1::natMX this study 
JVG1941 as JVG1367 ypl066w::kanMX this study 
JVG3888 ack1::natMX rom1::kanMX this study 
JVG2979 ack1::natMX tus1::kanMX this study 
JVG3372 ack1::natMX ypl066w::kanMX this study 
JVG3384 rom2::natMX ypl066w::kanMX this study 
JVG3393 tus1::natMX ypl066w::kanMX this study 
JVG1367 MATa his3Δ1 leu2Δ met15Δ ura3Δ Euroscarf 
SSC2711 
MATa his3Δ1, ura3Δ0, leu2Δ0, lys2Δ0  
ack1::kanMX4 TUS1-GFP::natMX6 
[YCplac33-pMET3-eCFP-TUB3::URA3] 
this study 
SSC2712 
MATa his3Δ1, ura3Δ0, leu2Δ0 
ypl066w::kanMX4 TUS1-GFP::natMX6 
[YCplac33-pMET3-eCFP-TUB3::URA3] 
this study 
SSC2714 
MATa his3Δ1, ura3Δ0, leu2Δ0, lys2Δ0 
ack1::kanMX4 ROM2-GFP::natMX6 
[YCplac33-pMET3-eCFP-TUB3::URA3] 
this study 
SSC2715 
MATa his3Δ1, ura3Δ0, leu2Δ0 
ypl066w::kanMX4 ROM2-GFP::natMX6 
[YCplac33-pMET3-eCFP-TUB3::URA3] 
this study 
SSC2763 MATa his3Δ1, ura3Δ0, leu2Δ0 TUS1-GFP::natMX6 [YCplac33-pMET3::URA3] this study 
SSC2766 MATa his3Δ1, ura3Δ0, leu2Δ0 ROM2-GFP::natMX6 [YCplac33-pMET3::URA3] this study 
 
 
!"#$%& '
!"#$!"#%&'"('()*+,-%
!"#$!"#%"'"('()&)*+,-.
!"#$!"#%"'"('()*./0$
!"
Sup. Figure1
" "/*0-123 453-.-(.-16780*"
#"
983:",2(*
!"#%
!"#%&1&(./0$
234$
234$&1&(+,-%
'
&
'
'
'
'
'
'
&
'
0 min 1 min 2 min
3 min 4 min 5 min 6 min
7 min 8 min 9 min 10 min
11 min 12 min 13 min 14 min
15 min 17 min 19 min
-1 min
37 min
*
A.
B. C. 
B. C.
A.
0.0
1.0
2.0
3.0
pVector pVectorpACK1 pACK1
rom2∆Wild type
pVector pVectorpTUS1 pTUS1
Wild type ypl066w
0.0
1.0
2.0
3.0
4.0
Sup Figure 4
A B
R
el
at
iv
e 
β­g
al
ac
to
si
da
se
 a
ct
iv
ity
R
el
at
iv
e 
β­g
al
ac
to
si
da
se
 a
ct
iv
ity
p<0.001
p>0.1 p<0.01
p>0.1
Band
Band 
(no septum)
Band 
(septum)Contracting Split bands
Signal at cell
 separationContracted
Spindle breakdownAnaphase B
Tu
s1
-G
FP
eC
FP
-T
ub
3
D
IC
A. TUS1-GFP ack1Δ
010
20
30
40
Band at
neck
MislocalisedSplit bands Repolarised
signal on
daughter side
%
 o
f p
os
t s
pi
nd
le
 b
re
ak
do
w
n 
ce
lls
 w
ith
 th
e 
in
di
ca
te
d 
R
om
2­
G
FP
 lo
ca
lis
at
io
n 
Signal at cell 
separation
WT
!"#$%%&'
A. ()*+,-./0!"#$%%&'
B.
Rom2­Myc
loading control
Wil
d ty
pe
ack
1
ypl0
66w
Tus1­Myc
Wil
d ty
pe
ack
1
ypl0
66w
loading control
A B
Sup Fig 7
